Pharmacological inhibition of Hippo pathway, with the novel kinase inhibitor XMU-MP-1, protects the heart against adverse effects during pressure overload. (2019)
Attributed to:
The role of plasma membrane calcium ATPase 4 (PMCA4) in modulating Plasmodium infection and malaria severity
funded by
Newton Fund
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bph.14795
PubMed Identifier: 31328787
Publication URI: http://europepmc.org/abstract/MED/31328787
Type: Journal Article/Review
Volume: 176
Parent Publication: British journal of pharmacology
Issue: 20
ISSN: 0007-1188